Table 3.
Antiretroviral Regimens
| Regimens | Number of patients taking the regimen (N=146) |
|---|---|
| NRTI+one anchor agent | 117 (80%) |
| NRTI+PI | 58 (40%) |
| NRTI+NNRTI | 44 (30%) |
| 3 drug FDC | 31 (21%) |
| NRTI+InSTI | 15 (10%) |
| NRTI+NNRTI+PI | 3 (2%) |
| NRTI+InSTI+PI | 12 (8%) |
| NRTI+NNRTI+InSTI | 2 (1%) |
| InSTI+PI | 4 (3%) |
| NRTI+NNRTI+PI+InSTI | 3 (2%) |
| Others | 5 (3%) |
FDC, fixed dose combination; InSTI, intergrase inhibitor; NNRTI, non-nucleotide reverse transcriptase inhibitor; NRTI, nucleotide/nucleoside reverse transcriptase inhibitor; PI, protease inhibitor.